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of inflammation other than CAD, PVD and clinically obviousRelevance of C-reactive protein levels in peritoneal dialysis
INF-INFL in peritoneal dialysis patients remain to be identi-patients.
fied.Background. C-reactive protein (CRP) levels are increased
in 30 to 50% of dialysis patients and predict cardiovascular
morbidity and mortality. It is usually considered that raised
CRP levels reflect underlying atherosclerosis. However, many Cardiovascular disease is the commonest cause of mor-patients may have clinically apparent cardiovascular disease
bidity and mortality in chronic dialysis patients [1, 2].without raised CRP levels. This study was designed to assess
Recent studies have shown that vascular disease is anboth the risk factors for high CRP levels and the usefulness
of the test as a marker of clinically apparent coronary artery inflammatory condition [3, 4]. In acute inflammatory
disease (CAD), peripheral vascular disease (PVD) and the conditions, cytokines initiate and coordinate the in-
presence of ongoing infections/inflammatory disorders (INF- flammatory response that includes increasing the hepaticINFL) in peritoneal dialysis patients.
production of acute phase reactants including C-reactiveMethods. A chart review of 190 prevalent peritoneal dialysis
protein (CRP) [5]. CRP is a predictor of subsequentpatients was performed. CRP, albumin, ferritin, erythropoietin
(EPO) dose and resistance, Kt/V, and residual renal function cardiovascular disease, cardiovascular mortality and all-
values were obtained and a history or presence of cardiovascu- cause mortality in both normal people [3] and patients
lar disease (CAD, PVD) and presence of INF-INFL recorded. on hemodialysis [6]. In peritoneal dialysis patients, pub-Data were analyzed by Chi-square, Spearman correlation and
lished results differ; CRP was predictive of myocardiallogistic regression.
infarction but not all cause mortality in one study [7]Results. A total of 31% of patients had a raised CRP. INF-
INFL was highly predictive of raised CRP levels (OR 16.97; whereas increased all cause mortality has been described
95% CI 5.41 to 53.14, P  0.000), whereas CAD and PVD in another [8]. However, the number of patients and the
either singly or in combination had no such association. The mortality rate in this latter study were low. Approxi-sensitivity/specificity for CRP as a test for INF-INFL was 83/
mately 30% of hemodialysis patients [8, 9] and up to77%. For CAD and PVD, the sensitivities were less than 40%
58% of peritoneal dialysis patients [7] have raised CRPand specificities 70%. Increased CRP values were more com-
mon in females but not in diabetics. Weak linear correlations levels. Most of these epidemiological studies used a sin-
existed between CRP levels and albumin, ferritin and residual gle CRP value as a predictor of outcome [6, 7, 10, 11],
renal function (r0.212, 0.228 and0.163 respectively, P which is surprising given the marked variation in individ-0.02). By regression analysis, INF-INFL predicted high CRP
ual CRP values in the same dialysis patient over timelevels, but CAD and PVD did not. The majority of patients
[12 and unpublished observations]. There are no studies(57%) with high CRP had no identifiable cause; 40% of these
patients had subsequent or previous normal CRP values. High of clinical correlations with high CRP levels in dialysis
transport status predicted high CRP levels (OR 7.28; 95% CI patients.
1.417 to 37.36, P  0.006). This study was designed to assess whether CRP levelsConclusions. The majority of elevated CRP levels in perito-
were related to known cardiovascular disease and otherneal dialysis patients occur without an obvious cause. Clinically
clinically apparent inflammatory-infectious (INF-INFL)apparent cardiovascular disease does not predict high CRP
levels. CRP levels vary over time in the same patient, from disorders in peritoneal dialysis patients. Correlations be-
normal to high or vice versa, for no obvious reason. Sources tween CRP and other inflammatory markers also were
determined.
Key words: cardiovascular disease, atherosclerosis, coronary artery dis-
ease, infection, chronic renal disease.
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Table 1. Laboratory values and demographics in 170 PD patientsCRP values taken within the previous four months were
with normal or high serum CRP levels
collected along with serum albumin, erythropoietin (EPO)
Normal CRP Raised CRPdosage, ferritin and parathyroid hormone (PTH). PTH
N  117 N  53 Plevels were measured as PTH may be a confounder for
Age 5216 55 14 0.258EPO resistance. Dialysis dose (Kt/V) and residual renal
Sex % female 49 68 0.023
function (RRF), performed within eight weeks of the CRP Albumin g/L 31.24.8 28.075.4 0.000
EPO U/week/kg 93104 125126 0.087values, were recorded. RRF was measured on account of
EPO resistancea 165193 260275 0.033its known relationship to outcome (discussed later in this
Ferritin lg/L 347283 482351 0.018
article). Ongoing (0 to 4 weeks prior to CRP values) clini- Kt/V 2.290.41 2.330.47 0.591
RRF 1/week 2526 2026 0.25cally apparent INF-INFL conditions were documented,
Diabetes 36% 30% 0.57as was the presence and/or past history of ischemic heart
PTH ng/L 279258 248260 0.471
disease and/or peripheral vascular disease. This informa-
Data were compared by the Student t test. Abbreviations are: CRP, C-reactivetion was obtained from examining all discharge summar- protein; EPO, erythropoietin; Kt/V, dialysis dose; RRF, residual renal function;
PTH, parathyroid hormone.ies, referral letters and letters from the nephrologist to
a As described in the Methods sectionthe general practitioner, as well as the nephrologists’
clinic notes. Forty percent of the patients were on perito-
neal cyclers. All our patients have Kt/V determinations Statistics
twice per year and a peritoneal equilibration test (PET; 4
Bivariate correlations with CRP values were assessedhours) six to eight weeks after starting peritoneal dialysis.
with Spearman rank correlation coefficients. DiscreteTransporter status was recorded because of its known
comparisons between normal and abnormal CRP valueseffect on outcome (discussed later in this article).
were assessed by chi-square analysis or Wilcoxon-rank
sum tests. Whether the effect of infection, CVD or PVDDefinitions
with CRP was modified by concomitant variables wereCoronary artery disease (CAD) was defined as the
analyzed by Mantel-Haenszel stratified analysis with ho-presence and/or history of angina, myocardial infarction,
mogeneity of odds ratios tested by the Breslow-Day test.coronary artery procedures and congestive heart failure.
Multiple logistic regression with backward stepping wasPeripheral vascular disease (PVD) was defined as the
used to select the most important independent predictorpresence and/or history of claudication, ischemic rest
of a high CRP. Odds ratios were estimated with 95% con-pain, ischemic ulcers, gangrene, previous amputation,
fidence intervals. Significance levels were set at alpha stroke, transient ischemic attack (TIA), or ultrasound
0.05.showing 50% carotid stenosis. The presence of INF-
INFL within four weeks of CRP determination included
the following conditions: peritonitis, pneumonia, collitis, RESULTS
severe exit site infections, acute arthritis, clinically active
A total of 170 charts were suitable for this study; 55%collagen vascular disease warranting treatment, infected
of these patients were female. The mean age was 53 foot ulcers, severe generalized dermatitis, calciphylaxis,
15 (range 19 to 81) years old; 31% of the patients had acarcinoma, active hepatitis. These criteria were chosen
raised CRP. Patients with increased CRP levels had lowerprior to the chart review.
albumin, higher ferritins, increased EPO resistance, and
were more likely to be female compared to patients withMeasurement
normal CRP (Table 1). Kt/V, RRF, age and the frequencyRoutine laboratory tests were used for hemoglobin,
of diabetes were not different between groups.albumin (bromocresol purple), urea, creatinine, ferritin,
With regard to CRP levels, the sensitivities and speci-and CRP levels (immune nephelometric assay). EPO
ficities for CAD, PVD and INF-INFL are given in Tableresistance was calculated by the weekly EPO dose di-
2. For INF-INFL, the sensitivity and specificity was 83%vided by the hematocrit, as used by others [12]. The
and 77%, respectively. CAD and PVD sensitivities werelower limit of detection for CRP in the St. Bonniface
between 36 and 40, and specificities between 69 and 71%.General Hospital laboratory is 0.5 mg/dL, with an upper
Fifty-seven percent of the patients with a raised CRPlimit of normal of 0.8 mg/dL. Upper limits of normal for
had none of these conditions. Several patients had twoferritin and PTH are 175 g/L and 72 ng/L, respectively.
or more of these conditions. In order to assess whetherResidual renal function (RRF) was calculated from the
very high levels of CRP would increase the sensitivityaverage of the urinary urea and creatinine clearance
of the test, the cut off point was raised to three timesand expressed as one per week. Transporter status was
normal. This resulted in 10 to 40% increases in sensitivi-obtained by a standard four-hour PET test. Inadequate
ties; however, specificities were reduced to less than 38%.dialysis was considered to be present when total (renal
peritoneal) Kt/V was 1.9. The causes of INF-INFL in patients with raised CRP
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Table 2. Number and frequency (% given in brackets) of coronary artery disease (CAD), peripheral vascular disease (PVD),
infection/inflammation (INF-INFL) in 170 PD patients related to serum CRP levels
No CAD, PVD,
CAD PVD CAD  PVD INF-INFL INF-INFL
Normal CRP
N  117 17 (14) 14 (12) 6 (5) 5 (4) 91 (78)
Increased CRP
N  53 12 (23) 8 (15) 4 (8) 20 (38) 30 (57)
Sensitivity % 40 36 38 83
Specificity % 70 69 71 77
Table 4. Predictive values for CVD, CAD, INF-INFL, EPO,Table 3. Cause of infection/inflammation in the 20 (38%)
patients with raised CRP levels and in the 5 (4%) ferritin, Kt/v and high transporter status on raised CRP levels
patients with normal CRP levels
Odds ratio 95% CI P
Raised CRP Normal CRP
CAD 1.59 0.704–3.605 0.260
PVD 1.28 0.507–3.305 0.588PVD (gangrene, infected ulcers) 7 2
Peritonitis 4 CAD  PVD 1.5 0.72–3.11 0.278
INF-INFL 16.97 5.41–53.14 0.000Arthritis (active) 3
Calciphylaxis 2 Ferritina (high) 2.83 1.43–5.61 0.002
Kt/V 1.9 1.69 0.504–5.63 0.385Carcinomatosis 1
Dermatitis 1 Male .456 0.226–0.90 0.022
Albuminb (low) 4.38 1.430–13.004 0.005Pyelonephritis 1
Chest infection 1 RRF 1.70 0.862–3.264 0.117
High transporter 7.277 1.417–37.36 0.006Active lupus, vasculitis 2
Hepatitis 1 a P  0.019, b P  0.003, increased predictive value by raising CRP set point
to 3 times normal
are shown in Table 3. The majority were caused by com-
available. In 5 of these 12 patients, previous values hadplications of PVD and peritonitis. INF-INFL had a
been normal. In 10 of these 30 patients, post-study (3 tomarked predictive effect for raised CRP levels by univar-
6 months) CRP values were obtained and CRP valuesiate and multivariant analysis (OR 17, 95% Cl 5.41 to
had become normal in four patients (Fig. 2).53.14, P  0.000, and OR 20.7, 95% Cl 5.93 to 72.19,
P  0.000, respectively). By univariate (Table 4) and
multivariate analysis, neither CAD, PVD nor both com- DISCUSSION
bined had any predictive effect on CRP levels. Raising
These results demonstrate that CRP level is a poorthe CRP threshold to more than three times normal had
predictor of clinically apparent CAD and PVD, and thatno additional benefit on these predictive values.
most PD patients have no obvious cause for a raisedSignificant but weak relationships between CRP and
CRP level. Furthermore, spontaneous fluctuations inserum albumin, and ferritin were found (Fig. 1). Insig-
CRP levels occur over time without explanation.nificant relationships between CRP and EPO dose and
C-reactive protein as a predictor of subsequent morbidEPO resistance were obtained (P  0.154 and 0.097,
events and death has received considerable attention inrespectively). On univariate and multivariate analysis,
the past several years both in non-renal [3, 14] and renalhigh ferritin predicted raised CRP levels. In the case of
failure patients [6–17]. Most of these published studiesalbumin, this was significant by univariate analysis but
consider that the rise in CRP combined with alterationsonly approached significance (P  0.07) in multivariate
in other acute phase reactants is probably an epiphenom-analysis. EPO resistance was higher with raised CRP by
enon. However, some evidence exists that CRP itselfboth univariate and multivariate analysis (P  0.041).
may be proinflammatory. For instance, CRP is able toA significant inverse relationship between RRF and
activate complement [15] and this occurs in atheroscle-CRP levels was found (Fig. 1), albeit a weak one (r 
rotic vessels [4] as well as in injured myocardium [16].0.163, P  0.015). However, by multivariate analysis,
Regardless of its precise role, serum CRP levels consis-this was no longer a predictor (P  0.18). High trans-
tently have been found to predict increased mortalityporter status predicted increased CRP (OR 7.28; 9% CI
and/or morbidity in renal and non-renal patients.1.417 to 37.36, P  0.006), but the number of such pa-
In hemodialysis patients, elevated CRP levels in-tients was small.
creased the risk of death threefold, and increased age,Patients with raised CRP levels but without INF-
female sex and diabetes were factors associated withINFL, CAD or PVD were studied further. In 12 of these
30 patients, pre-study (4 to 9 months) CRP values were high CRP [11]. Most deaths in the high CRP group were
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Fig. 1. Correlations between C-reactive protein (CRP) levels and serum albumin (B; r  212; P  0.006) and ferritin (A; r  0.228, P  0.008),
and residual renal function (RRF; C; r  0.103, P  0.015).
Fig. 2. CRP data in the patient cohort. (A) Twelve of 30 patients had a raised CRP value without coronary artery disease (CAD), peripheral
vascular disease (PVD) or clinically apparent inflammatory-infectious disorders (INF-INFL) during the four to nine month pre-study. (B) Ten of
30 patients with a raised CRP value in this study and were also without CAD, PVD or INF-INFL, had CRP data in the subsequent post-study (2
to 6 months).
cardiovascular. In another study, increased all-cause media thickness (abstract; Song et al, J Am Soc Nephrol
11:166A, 2000).mortality (and cardiovascular mortality) was associated
with high CRP levels in hemodialysis patients [6]. High None of these studies assessed the association between
a raised CRP level and the presence of clinically apparentCRP levels in that study superseded albumin levels in
predicting outcome. cardiovascular disease. Indeed, it has been our observa-
tion that many patients had markedly raised CRP levelsLess attention has been given to CRP levels in perito-
neal dialysis patients, and extrapolation from hemodialy- for no apparent reason. Taking into account the connec-
tion between worse cardiovascular outcome and raisedsis patients may be inappropriate considering that the
hemodialysis treatment itself may be an inflammatory CRP levels, I hypothesized that already declared cardio-
vascular disease, presumably signifying more advancedcondition causing CRP levels to rise [17]. High CRP
levels were associated with increased all-cause mortality, disease, would be correlated with a high CRP value. This
was not the case. The results clearly show that neitheralthough the mortality rate and number of patients in
that study were low [8]. However, in a very recent study CAD nor PVP predicted high CRP levels with poor
sensitivities and specificities for the test.with a larger cohort, 58% of the peritoneal dialysis pa-
tients had high CRP levels [7]. Followed over three years, The presence of INF-INFL predicted high CRP levels,
although the sensitivity and specificity were suboptimal.CRP was predictive of non-fatal myocardial infarction
but not all-cause mortality, which was significantly differ- Of greater interest is the novel finding that 57% of the
patients with high CRP levels had neither cardiovascularent than in hemodialysis. In peritoneal dialysis patients,
elevated CRP levels were predictive of carotid intima- disease nor INF-INFL. Furthermore, one half of these
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patients had CRP values greater than three times normal. correlated for other (than inflammatory) reasons. For
instance, high ferritins are associated with severe malnu-These results suggest that occult, non-cardiovascular in-
flammatory processes are occurring in these patients. trition [24]. More likely, the variables in this study are
related by being epiphenomena for the same conditionsPossibly, at that time the induced rise in CRP could play
a pro-inflammatory role in preclinical cardiovascular such as INF-INFL and cardiovascular disease, both clini-
cally apparent and occult.disease. Support for such a process has recently been
reported [18]. Haubitz and Brunkhorst demonstrated High peritoneal transport rate patients have a higher
mortality rate compared to other renal replacement ther-significant associations between serological tests for chla-
mydia infection and CRP levels in PD patients, and an apies [25, 26]. Inadequate fluid balance may contribute
to this higher mortality. Consideration has been givenincreased mortality risk from both [18].
Most studies of outcome measures with elevated CRP to the possibility that chronic inflammation of the perito-
neum, related to bioincompatibility of the dialysate [27],in dialysis patients have come from single CRP measures
only [6, 7, 11]. This is surprising in view of the marked may account for the increased mortality. However, in a
recent study no correlation between D/P creatinine andvariation in CRP levels reported in individual patients
[12]. The present study extends these observations fur- inflammatory markers (TNF, IL-1, CRP) were found
[28], which partially could be related to the small numberther. In approximately one third of those patients with
raised CRP values without an apparent cause, in whom of patients with abnormal blood levels of these inflam-
matory markers in that study. The present study of adata were available, the repeat values in 40% became
normal over the next few months. The same proportion much larger cohort of patients showed that high trans-
porter status predicted increased CRP levels. Althoughof these patients had preceding normal values. There-
fore, a large proportion of high CRP levels and their the finding was highly significant, the number of high
transporters [9] was relatively small, reducing the powerfluctuations have no apparent cardiovascular nor INF-
INFL cause. Future research is needed to assess other of the observation. This finding warrants further investi-
gation because the precise reason for the increased mor-putative risk factors.
Acute inflammatory disease is associated with multiple tality in high transporters remains elusive.
Residual renal function, relatively unimportant in he-laboratory abnormalities including decreased albumin
synthesis [9], and increased IL-1 and TNF, which them- modialysis patients, is responsible for a significant pro-
portion of total Kt/V in the first couple of years of perito-selves cause increased ferritin synthesis at the transcrip-
tional level [19] as well as increasing iron uptake by neal dialysis [29]. The rate of decrease in RRF is slower
in peritoneal dialysis patients compared to hemodialysishepatocytes [20]. Decreased erythropoiesis occurs, prob-
ably due to a cytokine mediated decrease in sensitivity [30], and is considered to be, at least partially, related
to the greater exposure to inflammatory stimuli by hemo-to erythropoietin [21]. Multiple relationships therefore
exist between these variables. In a series of dialysis pa- dialysis membrane-blood interaction [17]. The only known
independent risk factor for the decline in RRF in perito-tients (both HD and PD), EPO resistance was predicted
by a low albumin value, but when albumin was removed neal dialysis is the rate of peritonitis [31]. Our results,
showing a linear negative relationship between CRP andfrom the model, CRP and ferritin levels predicted EPO
resistance [13]. In hemodialysis patients, the EPO dosage RRF, support a role for chronic inflammation contribut-
ing to the rate of decline of RRF. However, it shouldwas related to serum albumin and to CRP levels, al-
though in this series very few patients had raised CRP be stressed that in a cross sectional study such as this
one, a single CRP value at one point in time may notlevels [22]. Our data show a weak linear relationship
between CRP and ferritin, and only a trend toward a be as valuable as a longitudinal study with several values.
This also would allow the rate of change of RRF tosignificant correlation between CRP and EPO resistance.
However, on multivariate analysis, EPO resistance was be assessed, thereby allowing a more clinically relevant
assessment of the relationship between RRF and chronica risk factor for raised CRP. With regard to serum albu-
min, a significant correlation between CRP and albumin inflammation to be obtained.
Cross sectional studies have widely known limitations.in this cohort was found similar to other reported in
hemodialysis patients [12, 22] and in peritoneal dialysis However, all patients were actively on peritoneal dialysis
at the time of this study, all the complete charts (withpatients [23]. It should be stressed that most of these
relationships are weak. all medical correspondence and discharge summaries)
were centralized in one location, and all the ongoingThere is a danger of over-interpreting these data for
several reasons. The associations are weak. Independent medical issues on all prevalent peritoneal dialysis pa-
tients were discussed weekly at rounds with all physiciansvariables may be confounded by other factors, for exam-
ple, a low albumin could be from peritoneal loss and/or and relevant personnel present. The data in this study
are the first part of an ongoing longitudinal study, whichfrom malnutrition, while a high ferritin could be from
iron administration. These factors themselves may be should be able to address several of the above issues.
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hances cardiovascular risk and mortality in hemodialysis patients.In conclusion, this study demonstrates that while 31%
Kidney Int 55:648–658, 1999of PD patients have a raised CRP, the majority of these 11. Iseki K, Tozawa M, Yoshi S, Fukiyama K: Serum C-reactive
patients have no clinically obvious inflammatory condi- protein (CRP) and risk of death in chronic dialysis patients.
Nephrol Dial Transplant 14:1956–1960, 1999tion. Many patients with known severe atherosclerotic
12. Kaysen GA, Dubin JA, Muller HG, et al: The HEMO studydisease have normal CRP levels. The finding suggests group. Kidney Int 58:346–352, 2000
that other subtle, as yet unknown causes of inflammation 13. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase
response predicts erythropoeiten resistance in hemodialysis andare occurring in these patients. Other possibilities include
peritoneal dialysis patients. Am J Kidney Dis 33:63–72, 1999gene polymorphism for expression of inflammatory medi-
14. Liuzzo G, Biasucci LM, Gallimore JR, et al: The prognostic
ator production or in inflammatory cell receptors. There value of C-reactive protein and serum amyloid A protein in severe
unstable patients. N Engl J Med 331:417–424, 1994are no data to support these putative causes but clearly,
15. Kaplan MH, Volanakis JE: Interaction of C-reactive protein com-conventional explanations do not explain the findings in
plexes with the complement system, 1: consumption of human
this study. The spontaneous fluctuations in CRP levels complement associated with the reaction of C-reactive protein
observed in this study, including in some patients with with pneumococcal polysaccharide and with choline phosphatides,
lecithin and sphingomyclin. J Immunol 112:2135–2145, 1974known cardiovascular disease, strongly suggest the possi-
16. Lagrand WK, Niessen HWM, Wolbink GJ, et al: C-reactive pro-bility that the inflammation associated with atherosclerosis tein colocalizes with complement in human hearts during acute
may be intermittent over time. Longitudinal studies myocardial infarction. Circulation 95:97–103, 1997
17. Haubitz M, Brinkhorst R, Wrenger E, et al: Chronic inductionshould clarify these possibilities. Routine CRP measure-
of C-reactive protein by hemodialysis, but not by peritoneal dialysisments in dialysis patients, as recommended in the litera-
therapy. Perit Dial Int 16:158–162, 1996
ture [32], cannot be supported by the results of this study. 18. Haubitz M, Brunkhorst R: C-reactive protein and chronic chla-
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